The effect of Monteluca on the symptoms of pyelonephritis in childre
Phase 4
Recruiting
- Conditions
- Pyelonephritis.Acute tubulo-interstitial nephritis
- Registration Number
- IRCT20190303042893N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with pyelonephritis with clinical symptoms of pyelonephritis and satisfaction with the studyThey are selected as the study group.
Satisfaction to participate in the study
Exclusion Criteria
Children with underlying illness of kidney, liver and heart.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of Pyelonephritis. Timepoint: Before taking the drug and 14 days after taking medication. Method of measurement: Registration of symptoms in the checklist.
- Secondary Outcome Measures
Name Time Method